Distinct molecular patterns based on proximal and distal sporadic colorectal cancer: arguments for different mechanisms in the tumorigenesis
- 337 Downloads
Background and aims
Colorectal cancer (CRC) ranks as the fourth most frequently diagnosed cancer worldwide. CRCs that arise proximally or distally to the splenic flexure show differences in epidemiologic incidence, morphology, and molecular alterations, suggesting the existence of two categories of CRC based on the site of origin. The aim of the present work is to investigate the histological and molecular differences between CRCs located proximally and distally to the splenic flexure, and their potential involvement in tumor prognosis and therapeutic strategies.
We evaluated 120 patients affected by sporadic CRC for clinicopathologic features, microsatellite instability (MSI), loss of heterozygosity (LOH) of chromosomes 18q, 8p, and 4p; they were also investigated for hMlh1, hMsh2, Fhit, p27, and Cox-2 immunostaining.
The mucinous histotype was more frequent in the proximal than in the distal CRCs (p<0.004). The frequency of MSI phenotype was higher in proximal than in distal tumors (p<0.001); moreover, reduced or absent hMlh1, Fhit, p27 immunohistochemical expressions were more frequent in proximal than in distal tumors (p<0.001 and 0.01 for p27). In contrast, the frequency of LOH in 18q was higher in distal than in proximal tumors (p=0.002). No significant differences were observed between proximal and distal tumors in the frequency of LOH in 8p and altered expression of hMsh2 and p53 protein.
These different features may reflect different genetic pathways of carcinogenesis and support the hypothesis of a different mechanism of cancer development between the proximal and the distal colon, with potential implications in the therapeutic approach.
KeywordsColon cancer Proximal colon Distal colon Molecular profile Therapeutic approach
This work was supported in part by a grant from “ Lega Italiana per la lotta contro i tumori”.
- 1.Society AC, http://www.cancer.org/docroot/NWS/content/NWS_1_1x_ACS_Updates_Colorectal_Screening_Guidelines_.asp (2003)Google Scholar
- 2.Berrino F, Capocaccia R, Estève J (1999) Survival of cancer patients in Europe: the EUROCARE-2 study. In: IARC Scientific Publications. International Agency for Research on Cancer, LyonGoogle Scholar
- 17.Arribas R, Ribas M, Risques RA, Masramon L, Tortola S, Marcuello E, Aiza G, Miro R, Capella G, Peinado MA (1999) Prospective assessment of allelic losses at 4p14-16 in colorectal cancer: two mutational patterns and a locus associated with poorer survival. Clin Cancer Res 5:3454–3459PubMedGoogle Scholar
- 20.Halling KC, French AJ, McDonnell SK, Burgart LJ, Schaid DJ, Peterson BJ, Moon-Tasson L, Mahoney MR, Sargent DJ, O’Connell MJ, Witzig TE, Farr GHJ, Goldberg RM, Thibodeau SN (1999) Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers. J Natl Cancer Inst 91:1295–1303PubMedCrossRefGoogle Scholar
- 23.Andachi H, Yashima K, Koda M, Kawaguchi K, Kitamura A, Hosoda A, Kishimoto Y, Shiota G, Ito H, Makino M, Kaibara N, Kavasaki H, Murawaki Y (2002) Reduced FHIT expression is associated with mismatch repair deficiency in human advanced colorectal carcinoma. Br J Cancer 87:441–445PubMedCrossRefGoogle Scholar
- 39.Jass JR, Sobin LH (1989). Springer, Berlin Heidelberg New YorkGoogle Scholar
- 42.Pahlman L (1998) Preoperative treatment of rectal cancer. In: Bleiberg H, Rougier P, Wilke H-J (eds) Management of colorectal cancer. Martin Dunitz, London, pp 156–166Google Scholar
- 46.Sarli L, Bottarelli L, Bader G, Iusco D, Pizzi S, Costi R, D’Adda T, Bertolani M, Roncoroni L, Bordi C (2004) Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q. Dis Colon Rectum 47:1467–1482PubMedGoogle Scholar
- 49.Thibodeau SN, French AJ, Cunningham JM, Tester D, Burgart LJ, Roche PC, McDonnell SK, Schaid DJ, Vockley CW, Michels VV, Farr GHJ, O’Connell MJ (1998) Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. Cancer Res 58:1713–1718PubMedGoogle Scholar
- 52.Sarli L, Bottarelli L, Azzoni C, Campanini N, Di Cola G, Bader G, Iusco D, Salvemini C, Caruso G, Donadei E, Pizzi S, D’Adda T, Renato C, Roncoroni L, Bordi C (2004) Abnormal Fhit protein expression and high frequency of microsatellite instability in sporadic colorectal cancer. Eur J Cancer 40:1581–1588PubMedCrossRefGoogle Scholar
- 58.Lanza GJ, Gafa R, Dubini A, Maestri I, Cavazzini L (1995) Clinico-pathological features and biological characterization of mucoid colorectal carcinoma. Pathologica 87:631–639Google Scholar
- 74.Russo A, Bazan V, Iacopetta B, Kerr D, Soussi T, Gebbia N (2005) The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment. J Clin Oncol 23:7518–7528PubMedCrossRefGoogle Scholar
- 81.Laurie JA, Moertel CG, Fleming TR, Wieand HS, Leigh JE, Rubin J, McCormack GW, Gerstner JB, Krook JE, Malliard J, et al (1989) Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic. J Clin Oncol 7:1156–1447Google Scholar
- 83.Ikeda Y, Mori M, Koyanagi N, Minagawa S, Kondo N, Fujimaru R, Kojima Y, Kondo A, Sugimachi K (1998) Possibility of different cancer development between the proximal and distal colon: comparison of the distribution between adenomatous polyps and cancer. Hepatogastroenterology 45:1583–1586PubMedGoogle Scholar